Asishana A Osho1, Anthony W Castleberry2, Laurie D Snyder3, Asvin M Ganapathi2, Sameer A Hirji4, Mark Stafford-Smith5, Shu S Lin2, R Duane Davis2, Matthew G Hartwig2. 1. School of Medicine, Duke University Medical Center, Durham, North Carolina. Electronic address: asishana.osho@duke.edu. 2. Department of Surgery, Duke University Medical Center, Durham, North Carolina. 3. Department of Medicine, Duke University Medical Center, Durham, North Carolina. 4. School of Medicine, Duke University Medical Center, Durham, North Carolina. 5. Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.
Abstract
BACKGROUND: The evidence behind the widely used pre-lung transplant glomerular filtration rate (GFR) cutoff of 50 mL/min per 1.73 m2 is limited. This study reviews data from a large cohort to assess outcomes associated with this historical cutoff and to estimate other possible cutoffs that might be appropriate in lung transplantation. METHODS: We conducted a retrospective cohort analysis of lung recipients at a single center. Recursive partitioning and receiver operating characteristics analysis were used to estimate other potential GFR cutoffs with 1-year mortality as the outcome. Postoperative outcomes around the various cutoffs, including survival, acute kidney injury, and dialysis, were assessed using χ2, Kaplan-Meier, and Cox regression methods. RESULTS: A total of 794 lung recipients met study inclusion criteria. Compared with 778 patients with GFR 50 mL/min per 1.73 m2 or greater at time of transplant, 16 patients with GFR below this cutoff were older and more likely to have restrictive disease. One-year mortality below the cutoff was 31.3% compared with 15.1% above the cutoff (p=0.021). Recursive partitioning estimated potential GFR cutoff values between 46 and 61 mL/min per 1.73 m2. Patients with GFR below these cutoffs were at significantly higher risk for adverse outcomes (p<0.05). Receiver operating characteristics analysis was less successful at identifying meaningful cutoff values with areas under the curve approximately 0.5. CONCLUSIONS: Study results support the practice of requiring candidate GFR 50 mL/min per 1.73 m2 or greater for lung transplantation. Future work should focus on reproducing the analysis in a larger cohort of patients including more individuals with low GFR.
BACKGROUND: The evidence behind the widely used pre-lung transplant glomerular filtration rate (GFR) cutoff of 50 mL/min per 1.73 m2 is limited. This study reviews data from a large cohort to assess outcomes associated with this historical cutoff and to estimate other possible cutoffs that might be appropriate in lung transplantation. METHODS: We conducted a retrospective cohort analysis of lung recipients at a single center. Recursive partitioning and receiver operating characteristics analysis were used to estimate other potential GFR cutoffs with 1-year mortality as the outcome. Postoperative outcomes around the various cutoffs, including survival, acute kidney injury, and dialysis, were assessed using χ2, Kaplan-Meier, and Cox regression methods. RESULTS: A total of 794 lung recipients met study inclusion criteria. Compared with 778 patients with GFR 50 mL/min per 1.73 m2 or greater at time of transplant, 16 patients with GFR below this cutoff were older and more likely to have restrictive disease. One-year mortality below the cutoff was 31.3% compared with 15.1% above the cutoff (p=0.021). Recursive partitioning estimated potential GFR cutoff values between 46 and 61 mL/min per 1.73 m2. Patients with GFR below these cutoffs were at significantly higher risk for adverse outcomes (p<0.05). Receiver operating characteristics analysis was less successful at identifying meaningful cutoff values with areas under the curve approximately 0.5. CONCLUSIONS: Study results support the practice of requiring candidate GFR 50 mL/min per 1.73 m2 or greater for lung transplantation. Future work should focus on reproducing the analysis in a larger cohort of patients including more individuals with low GFR.
Authors: Pablo R Lujan; Carlos Chiurchiu; Walter Douthat; Javier de Arteaga; Jorge de la Fuente; Raul H Capra; Pablo U Massari Journal: Transplantation Date: 2012-09-27 Impact factor: 4.939
Authors: Hannah S Kilbride; Paul E Stevens; Gillian Eaglestone; Sarah Knight; Joanne L Carter; Michael P Delaney; Christopher K T Farmer; Jean Irving; Shelagh E O'Riordan; R Neil Dalton; Edmund J Lamb Journal: Am J Kidney Dis Date: 2012-08-11 Impact factor: 8.860
Authors: Edmund Q Sanchez; Larry B Melton; Srinath Chinnakotla; Henry B Randall; Greg J McKenna; Richard Ruiz; Nicholas Onaca; Marlon F Levy; Robert M Goldstein; Goran B Klintmalm Journal: Transplantation Date: 2010-01-27 Impact factor: 4.939
Authors: William A Cooper; Sean M O'Brien; Vinod H Thourani; Robert A Guyton; Charles R Bridges; Lynda A Szczech; Rebecca Petersen; Eric D Peterson Journal: Circulation Date: 2006-02-20 Impact factor: 29.690
Authors: Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion Journal: N Engl J Med Date: 2003-09-04 Impact factor: 91.245
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Jeremiah R Brown; Richard P Cochran; Bruce J Leavitt; Lawrence J Dacey; Cathy S Ross; Todd A MacKenzie; Karyn S Kunzelman; Robert S Kramer; Felix Hernandez; Robert E Helm; Benjamin M Westbrook; Robert F Dunton; David J Malenka; Gerald T O'Connor Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Asishana A Osho; Sameer A Hirji; Anthony W Castleberry; Michael S Mulvihill; Asvin M Ganapathi; Paul J Speicher; Babatunde Yerokun; Laurie D Snyder; Robert D Davis; Mathew G Hartwig Journal: Clin Transplant Date: 2017-04-17 Impact factor: 2.863
Authors: Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos Journal: J Heart Lung Transplant Date: 2021-07-24 Impact factor: 13.569